HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression.

Abstract
gamma-Glutamylcysteine synthetase (gamma-GCS) is a key enzyme in glutathione (GSH) synthesis, and is thought to play a significant role in intracellular detoxification, especially of anticancer drugs. Increased levels of GSH are commonly found in the drug-resistant human cancer cells. We designed a hammerhead ribozyme against gamma-GCS mRNA (anti-gamma-GCS Rz), which specifically down-regulated gamma-GCS gene expression in the HCT-8 human colon cancer cell line. The aim of this study was to reverse the cisplatin and multidrug resistance for anticancer drugs. The cisplatin-resistant HCT-8 cells (HCT-8DDP cells) overexpressed MRP and MDR1 genes, and showed resistance to not only cisplatin (CDDP), but also doxorubicin (DOX) and etoposide (VP-16). We transfected a vector expressing anti-gamma-GCS Rz into the HCT-8DDP cells (HCT-8DDP/Rz). The anti-gamma-GCS Rz significantly suppressed MRP and MDR, and altered anticancer drug resistance. The HCT-8DDP/Rz cells were more sensitive to CDDP, DOX and VP-16 by 1.8-, 4.9-, and 1.5-fold, respectively, compared to HCT-8DDP cells. The anti-gamma-GCS Rz significantly down-regulated gamma-GCS gene expression as well as MRP/MDR1 expression, and reversed resistance to CDDP, DOX and VP-16. These results suggested that gamma-GCS plays an important role in both cisplatin and multidrug resistance in human cancer cells.
AuthorsJ Nagata, H Kijima, H Hatanaka, S Asai, H Miyachi, A Takagi, T Miwa, T Mine, H Yamazaki, M Nakamura, T Kondo, K J Scanlon, Y Ueyama
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 286 Issue 2 Pg. 406-13 (Aug 17 2001) ISSN: 0006-291X [Print] United States
PMID11500053 (Publication Type: Journal Article)
CopyrightCopyright 2001 Academic Press.
Chemical References
  • Antineoplastic Agents
  • RNA, Catalytic
  • RNA, Neoplasm
  • Tetrazolium Salts
  • Thiazoles
  • Glutamate-Cysteine Ligase
  • thiazolyl blue
  • Glutathione
  • Cisplatin
Topics
  • Antineoplastic Agents (therapeutic use)
  • Cisplatin (therapeutic use)
  • Colonic Neoplasms (genetics, metabolism, therapy)
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm
  • Glutamate-Cysteine Ligase (genetics)
  • Glutathione (antagonists & inhibitors)
  • Humans
  • RNA, Catalytic (therapeutic use)
  • RNA, Neoplasm (biosynthesis, genetics)
  • Tetrazolium Salts (chemistry)
  • Thiazoles (chemistry)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: